Unknown

Dataset Information

0

Invasive Nocardiosis in Transplant and Nontransplant Patients: 20-Year Experience in a Tertiary Care Center.


ABSTRACT:

Objective

To present the clinical characteristics and outcome of transplant and nontransplant patients with invasive nocardiosis.

Patients and methods

We conducted a retrospective chart review of 110 patients 18 years and older diagnosed with culture-proven invasive nocardiosis (defined as the presence of clinical signs and/or radiographic abnormalities) between August 1, 1998, and November 30, 2018. Information on demographic, clinical, radiographic, and microbiological characteristics as well as mortality was collected.

Results

One hundred ten individuals with invasive nocardiosis were identified, of whom 54 (49%) were transplant and 56 nontransplant (51%) patients. Most transplant patients were kidney and lung recipients. The overall mean age was 64.9 years, and transplant patients had a higher prevalence of diabetes and chronic kidney disease. A substantial proportion of nontransplant patients were receiving corticosteroids (39%), immunosuppressive medications (16%), and chemotherapy (9%) and had chronic obstructive pulmonary disease (20%), rheumatologic conditions (18%), and malignant neoplasia (18%). A higher proportion of transplant patients (28%) than nontransplant patients (4%) received trimethoprim-sulfamethoxazole prophylaxis. In both groups, the lung was the most common site of infection. Seventy percent of all Nocardia species isolated were present in almost equal proportion: N brasiliensis (16%), N farcinica (16%), N nova (15%), N cyriacigeorgia (13%), and N asteroides (11%). More than 90% of isolates were susceptible to trimethoprim-sulfamethoxazole, linezolid, and amikacin. There was no significant difference in mortality between the 2 groups at 1, 6, and 12 months after the initial diagnosis.

Conclusion

The frequency of invasive Nocardia infection was similar in transplant and nontransplant patients and mortality at 1, 6, and 12 months was similar in both groups. Trimethoprim-sulfamethoxazole prophylaxis failed to prevent Nocardia infection.

SUBMITTER: Harris DM 

PROVIDER: S-EPMC8105525 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7733773 | biostudies-literature
| S-EPMC7102384 | biostudies-literature
| S-EPMC6940105 | biostudies-literature
| S-EPMC7803433 | biostudies-literature
| S-EPMC6939473 | biostudies-literature
| S-EPMC7834458 | biostudies-literature
| S-EPMC5493186 | biostudies-other
| S-EPMC7523794 | biostudies-literature
| S-EPMC5451693 | biostudies-other
| S-EPMC5559798 | biostudies-other